Drug Type TCR therapy |
Synonyms MAGEA4 antigenspecific RetroNectin TCR gene therapy Takara Bio, MAGEA4 antigenspecific TCR modified lymphocytes Takara Bio, MAGEA4 TCRtransduced Tcell therapy Takara Bio + [2] |
Target |
Mechanism MAGEA4 inhibitors(Melanoma-associated antigen 4 inhibitors), Gene transference, Immunologic cytotoxicity |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 1 | JP | 01 Apr 2014 |